BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 7065989)

  • 1. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
    Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E
    Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulants in clinical practice.
    Brozović M
    Semin Hematol; 1978 Jan; 15(1):27-34. PubMed ID: 622584
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Dec; (8):209-24. PubMed ID: 12603878
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of venous thromboembolic disease.
    Gallus AS; Hirsh J
    Semin Thromb Hemost; 1976 Apr; 2(4):291-331. PubMed ID: 798277
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of venous thromboembolism.
    Ginsberg JS
    N Engl J Med; 1996 Dec; 335(24):1816-28. PubMed ID: 8943165
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant therapy: through a glass darkly.
    Hampton JW
    Am Fam Physician; 1974 Feb; 9(2):100-4. PubMed ID: 4810867
    [No Abstract]   [Full Text] [Related]  

  • 11. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current data on diagnosis and treatment of thromboembolic states].
    Zosin P; Roth L
    Med Interna (Bucur); 1972 Aug; 24(8):947-58. PubMed ID: 5080893
    [No Abstract]   [Full Text] [Related]  

  • 17. [General postoperative thrombosis prevention using anticoagulants].
    Hochuli E; Schneider D; Frey P
    Zentralbl Gynakol; 1969 Sep; 91(37):1211-8. PubMed ID: 5368212
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
    Enrico JF
    Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis].
    Hernigou P; Février MJ; Kergrohen F
    Rev Chir Orthop Reparatrice Appar Mot; 1993; 79(7):577-85. PubMed ID: 8085039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.